(19)
(11) EP 4 225 289 A1

(12)

(43) Date of publication:
16.08.2023 Bulletin 2023/33

(21) Application number: 21894166.4

(22) Date of filing: 20.11.2021
(51) International Patent Classification (IPC): 
A61K 31/167(2006.01)
A61K 9/00(2006.01)
 A61P 23/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 23/02; A61K 31/445; A61K 9/0056; A61K 9/006; A61K 9/0019; A61K 9/0014
(86) International application number:
PCT/IB2021/060776
(87) International publication number:
WO 2022/107084 (27.05.2022 Gazette 2022/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 21.11.2020 IN 202041050763

(71) Applicant: CELLIX BIO PRIVATE LIMITED
Hyderabad 500033 (IN)

(72) Inventor:
  • KANDULA, Mahesh
    G.medapadu 533434 (IN)

(74) Representative: Isarpatent 
Patent- und Rechtsanwälte Barth Charles Hassa Peckmann & Partner mbB Friedrichstrasse 31
80801 München
80801 München (DE)

   


(54) PHARMACEUTICAL COMPOSITIONS FOR USE IN THE MANAGEMENT AND TREATMENT OF PAIN